High-dose rituximab in the conditioning regimen before allogeneic stem cell transplantation for relapsed lymphomas: protective role of the antibody on GvHD incidence

被引：0
|
作者：
Corradini, P.
Sarina, B.
Carniti, C.
Patriarca, F.
Carella, A.
Levis, A.
Bosi, A.
Falda, M.
Di Bartolomeo, P.
Olivares, C.
Gimondi, S.
Rambaldi, A.
Dodero, A.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S421 / S421
页数：1
相关论文
共 50 条
  • [21] High-dose idarubicin and busulphan as conditioning regimen to autologous stem cell transplantation in acute myeloid leukaemia
    Ferrara, F
    Palmieri, S
    De Simone, M
    D'Amico, MR
    Fasanaro, A
    Viola, A
    Annunziata, M
    Mele, G
    BONE MARROW TRANSPLANTATION, 2004, 33 : S233 - S233
  • [22] BORTEZOMIB AND HIGH-DOSE MELPHALAN AS CONDITIONING REGIMEN BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE IN A UNIVERSITARY HOSPITAL
    de Miguel, D.
    Morales, D.
    San Roman, I.
    Golbano, N.
    Diaz, M.
    Arbeteta, J.
    Herrero, S.
    Subira, D.
    PInedo, B.
    HAEMATOLOGICA, 2012, 97 : 622 - 622
  • [23] The role of ifosfamide in cytoreduction, stem cell mobilization and high-dose therapy in relapsed/refractory malignant lymphomas
    Hagemeister, FB
    Diehl, V
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 : 1 - 2
  • [24] Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens
    Bertz, H
    Illerhaus, G
    Veelken, H
    Finke, J
    ANNALS OF ONCOLOGY, 2002, 13 (01) : 135 - 139
  • [25] High incidence of acute GvHD after allogeneic blood stem cell transplantation following minimal intensive conditioning.
    Kobbe, G
    Aivado, M
    Huenerlituerkoglu, A
    Schneider, P
    Rong, A
    Zohren, F
    Schubert, D
    Pape, H
    Neumann, F
    Germing, U
    Gattermann, N
    Haas, R
    BLOOD, 2000, 96 (11) : 784A - 784A
  • [26] Upfront stem cell transplantation with the rituximab/TBI/CY high-dose regimen is an effective treatment for mantle cell lymphoma
    Seyfarth, B
    Sonnen, R
    Pott, C
    Kneba, M
    Schmitz, N
    Dreger, P
    BONE MARROW TRANSPLANTATION, 2002, 29 : S89 - S89
  • [27] Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin's Lymphoma
    Rivas, Maria Marta
    Berro, Mariano
    Yantorno, Sebastian
    Prates, Maria Virginia
    Milone, Jorge H.
    Basquiera, Ana Lisa
    Berreta, Adriana
    Garcia, Juan
    Remaggi, Guillermina
    Rolon, Juliana Martinez
    Arbelbide, Jorge
    Makiya, Monica
    Dibar, Eduardo
    Requejo, Alejandro
    Feldman, Leonardo Julio, Sr.
    Milovic, Vera
    Foncuberta, Maria Cecilia
    Burgos, Ruben
    Kusminsky, Gustavo Daniel
    BLOOD, 2013, 122 (21)
  • [28] ALLOGENEIC STEM CELL TRANSPLANTATION WITH REDUCED INTENSITY CONDITIONING REGIMEN IN PATIENTS WITH RELAPSED HODGKIN'S LYMPHOMA
    Marta Rivas, M.
    Berro, M.
    Virginia Prates, M.
    Yantorno, S.
    Milone, J.
    Lisa Basquiera, A.
    Adriana, B.
    Jose Garcia, J.
    Remaggi, G.
    Martinez Rolon, J.
    Burgos, R.
    Foncuberta, C.
    Feldman, L.
    Jaimovich, G.
    Real, J.
    Milovic, V.
    Arberbide, J.
    Makiya, M.
    Dibar, E.
    Kusminsky, G.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S172 - S173
  • [29] High-dose rituximab in combination with autologous stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma
    Shi, Yi-Fen
    Zhou, Shu-Juan
    Sun, Lan
    Yu, Kang
    Chen, Yi
    MEDICINA CLINICA, 2020, 155 (06): : 235 - 241
  • [30] High-dose therapy with stem-cell transplantation in the malignant lymphomas
    Winter, JN
    ONCOLOGY-NEW YORK, 1999, 13 (12): : 1635 - 1645
12345